CRON - Cronos Group Inc Stock Price, Fair Value and News

$2.52+0.06 (+2.44%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CRON Price Action

Last 7 days

1.6%

Last 30 days

-0.8%

Last 90 days

0.8%

Trailing 12 Months

24.1%

CRON RSI Chart

CRON Valuation

Market Cap

964.9M

Price/Earnings (Trailing)

24.01

Price/Sales (Trailing)

5.48

EV/EBITDA

4.16

Price/Free Cashflow

-179.68

CRON Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CRON Fundamentals

CRON Revenue

Revenue (TTM)

176.2M

Rev. Growth (Yr)

4.79%

Rev. Growth (Qtr)

10.34%

CRON Earnings

Earnings (TTM)

40.2M

Earnings Growth (Yr)

239.21%

Earnings Growth (Qtr)

171.32%

CRON Profitability

EBT Margin

23.39%

Return on Equity

3.55%

Return on Assets

3.41%

Free Cashflow Yield

-0.56%

CRON Investor Care

Shares Dilution (1Y)

0.16%

Diluted EPS (TTM)

0.11

CRON Alerts

Big jump in Earnings (Y/Y)

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	168.4M	173.9M	176.2M	0
2024	129.1M	142.0M	154.6M	161.8M
2023	107.6M	106.3M	114.2M	120.3M
2022	94.4M	102.6M	104.1M	110.5M
2021	60.7M	67.0M	73.3M	79.6M
2020	961.1M	768.7M	271.6M	54.4M
2019	0	0	0	1.2B
2018	0	0	0	0
2017	0	0	0	0
2016	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Cronos Group Inc

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

CEO	Mr. Michael Ryan Gorenstein J.D.
WEBSITE	thecronosgroup.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	447

Cronos Group Inc Frequently Asked Questions

What is the ticker symbol for Cronos Group Inc? What does CRON stand for in stocks?

CRON is the stock ticker symbol of Cronos Group Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cronos Group Inc (CRON)?

As of Wed Dec 03 2025, market cap of Cronos Group Inc is 964.89 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CRON stock?

You can check CRON's fair value in chart for subscribers.

Is Cronos Group Inc a good stock to buy?

The fair value guage provides a quick view whether CRON is over valued or under valued. Whether Cronos Group Inc is cheap or expensive depends on the assumptions which impact Cronos Group Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CRON.

What is Cronos Group Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, CRON's PE ratio (Price to Earnings) is 24.01 and Price to Sales (PS) ratio is 5.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CRON PE ratio will change depending on the future growth rate expectations of investors.